Indraprastha Medical Corporation Limited (IN:INDRAMEDCO)
:INDRAMEDCO
Want to see IN:INDRAMEDCO full AI Analyst Report?
Top Page
Indraprastha Medical Corporation Limited
(INDRAMEDCO)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹457.00
▲(0.21% Upside)
Action:ReiteratedDate:01/21/26
The score is supported primarily by strong multi-year financial performance (revenue growth and improving margins) and a solid, low-leverage balance sheet. However, very weak technical momentum (below key moving averages with negative MACD and extremely low RSI/Stoch) and softer 2025 cash flow trends materially reduce the overall rating.
Positive Factors
Multi-year revenue growth
Sustained revenue growth over multiple years reflects expanding patient volumes and service mix at the hospital. That scale supports fixed-cost absorption and long-term revenue resilience, providing a durable foundation for earnings stability and reinvestment over the next 2–6 months.
Negative Factors
Declining cash balances
A year-over-year drop in cash reserves signals tighter liquidity, which can constrain short-term operational flexibility and payment cycles. If sustained, lower cash balances raise the importance of careful working-capital management and may limit rapid response to demand or investment opportunities.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year revenue growth
Sustained revenue growth over multiple years reflects expanding patient volumes and service mix at the hospital. That scale supports fixed-cost absorption and long-term revenue resilience, providing a durable foundation for earnings stability and reinvestment over the next 2–6 months.
Read all positive factors
Indraprastha Medical Corporation Limited (INDRAMEDCO) vs. iShares MSCI India ETF (INDA)
Market Cap
₹37.19B
Dividend Yield0.96%
Average Volume (3M)33.92K
Price to Earnings (P/E)25.1
Beta (1Y)1.43
Revenue Growth8.53%
EPS Growth21.02%
CountryIN
Employees2,977
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)4.80
Shares Outstanding91,673,000
10 Day Avg. Volume18,340
30 Day Avg. Volume33,918
Financial Highlights & Ratios
PEG Ratio0.75
Price to Book (P/B)6.04
Price to Sales (P/S)2.66
P/FCF Ratio29.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)21.5
Revenue Forecast (FY)₹15.98B
Indraprastha Medical Corporation Limited Business Overview & Revenue Model
Company Description
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow t...
How the Company Makes Money
INDRAMEDCO primarily makes money by delivering hospital-based healthcare services and charging patients, insurers, and other payors for clinical care. Key revenue streams typically include: (1) Inpatient services: room/bed charges, ICU charges, nu...
Indraprastha Medical Corporation Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
75
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.05B | 13.56B | 12.45B | 10.99B | 8.88B | 6.13B |
| Gross Profit | 3.81B | 3.50B | 3.13B | 6.25B | 4.79B | 3.47B |
| EBITDA | 2.78B | 2.44B | 2.07B | 1.61B | 1.17B | 409.48M |
| Net Income | 1.75B | 1.61B | 1.24B | 861.50M | 586.20M | 23.30M |
Balance Sheet | ||||||
| Total Assets | 9.54B | 8.52B | 7.23B | 5.55B | 4.62B | 4.32B |
| Cash, Cash Equivalents and Short-Term Investments | 4.61B | 3.19B | 2.24B | 1.36B | 660.10M | 296.10M |
| Total Debt | 313.40M | 327.60M | 339.50M | 24.80M | 53.10M | 78.18M |
| Total Liabilities | 2.96B | 2.55B | 2.45B | 1.76B | 1.36B | 1.59B |
| Stockholders Equity | 6.58B | 5.97B | 4.78B | 3.79B | 3.25B | 2.73B |
Cash Flow | ||||||
| Free Cash Flow | 808.10M | 1.20B | 1.31B | 998.90M | 418.10M | 69.35M |
| Operating Cash Flow | 935.10M | 1.57B | 2.00B | 1.44B | 712.90M | 278.98M |
| Investing Cash Flow | -1.47B | -1.11B | -1.58B | -1.08B | -511.00M | -201.62M |
| Financing Cash Flow | -56.60M | -458.80M | -323.80M | -260.40M | -33.70M | -31.47M |
Indraprastha Medical Corporation Limited Technical Analysis
Positive
456.05
Price Trends
403.46
Positive
426.70
Positive
460.79
Negative
Market Momentum
8.46
Negative
56.54
Neutral
72.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDRAMEDCO, the sentiment is Positive. The current price of 456.05 is above the 20-day moving average (MA) of 406.79, above the 50-day MA of 403.46, and below the 200-day MA of 460.79, indicating a neutral trend. The MACD of 8.46 indicates Negative momentum. The RSI at 56.54 is Neutral, neither overbought nor oversold. The STOCH value of 72.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:INDRAMEDCO.
Indraprastha Medical Corporation Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ₹1.11T | 50.39 | ― | 0.27% | 14.52% | 37.54% | |
66 Neutral | ₹972.56B | 84.46 | ― | 0.14% | 24.44% | 40.69% | |
65 Neutral | ₹37.16B | 42.27 | ― | 0.16% | 12.97% | 29.45% | |
65 Neutral | ₹297.24B | 83.79 | ― | 0.04% | 17.16% | 1.24% | |
64 Neutral | ₹37.19B | 25.06 | ― | 0.96% | 8.53% | 21.02% | |
61 Neutral | ₹700.68B | 86.12 | ― | 0.11% | 15.99% | 24.81% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:INDRAMEDCO
Indraprastha Medical Corporation Limited
402.05
3.02
0.76%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
7,751.05
776.65
11.14%
IN:ARTEMISMED
Artemis Medicare Services Ltd.
240.65
-18.69
-7.21%
IN:FORTIS
Fortis Healthcare Ltd.
952.95
286.14
42.91%
IN:MAXHEALTH
Max Healthcare Institute Ltd
1,004.20
-101.82
-9.21%
IN:MEDANTA
Global Health Limited
1,136.40
-40.63
-3.45%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.